0001209191-20-059523.txt : 20201119
0001209191-20-059523.hdr.sgml : 20201119
20201119185711
ACCESSION NUMBER: 0001209191-20-059523
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200919
FILED AS OF DATE: 20201119
DATE AS OF CHANGE: 20201119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moriarty John B
CENTRAL INDEX KEY: 0001564621
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39712
FILM NUMBER: 201330026
MAIL ADDRESS:
STREET 1: ALEXION PHARMACEUTICALS
STREET 2: 352 KNOTTER DRIVE
CITY: CHESHIRE
STATE: CT
ZIP: 06410
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001750284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300409740
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: (415) 651-3316
MAIL ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-19
0
0001750284
Olema Pharmaceuticals, Inc.
OLMA
0001564621
Moriarty John B
C/O OLEMA PHARMACEUTICALS, INC.
512 2ND STREET, 4TH FLOOR
SAN FRANCISCO
CA
94107
0
1
0
0
EVP, Ch. Legal Officer & Sec.
Stock Option (Right to Buy)
4.824
2020-09-19
4
A
0
252060
0.00
A
2030-09-18
Common Stock
252060
252060
D
Stock Option (Right to Buy)
19.00
2020-11-18
4
A
0
161406
0.00
A
2030-11-17
Common Stock
161406
161406
D
25% of the shares subject to the option vest on September 8, 2021 and 1/48 of the total number of shares subject to the option vest each month
thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. The stock option is early exercisable.
25% of the shares subject to the option vest on November 18, 2021 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
/s/ John B. Moriarty, Jr.
2020-11-19